DE60033530T2
(de)
|
1999-08-24 |
2007-10-31 |
Medarex Inc. |
Humane antikörper gegen ctla-4 und deren verwendungen
|
WO2006007448A2
(en)
|
2004-06-17 |
2006-01-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions and related methods of use
|
SI2161336T1
(sl)
|
2005-05-09 |
2013-11-29 |
Ono Pharmaceutical Co., Ltd. |
Humana monoklonska protitelesa za programirano smrt 1 (PD-1) in postopki za zdravljenje raka ob uporabi anti-PD-1 protiteles samih ali v kombinaciji z drugimi imunoterapevtiki
|
BRPI0613361A2
(pt)
|
2005-07-01 |
2011-01-04 |
Medarex Inc |
anticorpo monoclonal humano isolado, composição, imunoconjugado, molécula biespecìfica, molécula de ácido nucleico isolada, vetor de expressão, célula hospedeira, camundongo transgênico, método para modular uma resposta imune num indivìduo, método para inibir crescimento de células tumorais num indivìduo, método para tratar uma doença infecciosa num indivìduo, método para aumentar uma resposta imune a um antìgeno num indivìduo, método para tratar ou prevenir uma doença inflamatória num indivìduo e método para preparar o anticorpo anti-pd-l1
|
EP2535354B1
(en)
|
2007-06-18 |
2017-01-11 |
Merck Sharp & Dohme B.V. |
Antibodies to human programmed death receptor pd-1
|
EP2931738B1
(en)
|
2012-12-13 |
2019-02-06 |
Aduro Biotech, Inc. |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
JP6280912B2
(ja)
*
|
2013-03-14 |
2018-02-14 |
武田薬品工業株式会社 |
複素環化合物
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
CN105188373B
(zh)
|
2013-05-18 |
2017-09-22 |
艾杜罗生物科技公司 |
抑制“干扰素基因刺激蛋白”依赖性信号传导的组合物和方法
|
MX354057B
(es)
|
2013-05-18 |
2018-02-09 |
The Regents Of The Univ Of California Star |
Composiciones y métodos para activar la señalización dependiente del "estimulador del gene de interferón".
|
ES2642074T3
(es)
|
2013-09-04 |
2017-11-15 |
Bristol-Myers Squibb Company |
Compuestos útiles como inmunomoduladores
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
US10450341B2
(en)
|
2014-06-04 |
2019-10-22 |
Glaxosmithkline Intellectual Property Development Limited |
Cyclic di-nucleotides as modulators of STING
|
CN106999536B
(zh)
|
2014-09-11 |
2020-11-27 |
百时美施贵宝公司 |
Pd-1/pd-l1及cd80(b7-1)/pd-l1蛋白质/蛋白质相互作用的大环抑制剂
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
EP3233882B1
(en)
|
2014-12-16 |
2019-10-30 |
Kayla Therapeutics |
Fluorinated cyclic dinucleotides for cytokine induction
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9944678B2
(en)
|
2014-12-19 |
2018-04-17 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US20160222060A1
(en)
|
2015-02-04 |
2016-08-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
MY190404A
(en)
|
2015-03-10 |
2022-04-21 |
Aduro Biotech Inc |
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US20180110796A1
(en)
|
2015-04-07 |
2018-04-26 |
Spring Bank Pharmaceuticals, Inc. |
Compositions and methods for the treatment of hbv infection
|
TW201717968A
(zh)
|
2015-07-14 |
2017-06-01 |
春季銀行製藥公司 |
誘導rig-i和其他模式辨識受體之化合物及組成物
|
CN114272371A
(zh)
*
|
2015-07-29 |
2022-04-05 |
诺华股份有限公司 |
包含抗pd-1抗体分子的联合疗法
|
EP3334745B1
(en)
|
2015-08-13 |
2024-05-15 |
Merck Sharp & Dohme LLC |
Cyclic di-nucleotide compounds as sting agonists
|
US9809597B2
(en)
|
2015-08-20 |
2017-11-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
EP3368072A4
(en)
|
2015-10-28 |
2019-07-03 |
Aduro BioTech, Inc. |
COMPOSITIONS AND METHOD FOR ACTIVATING SIGNALING DEPENDENT ON THE STIMULATOR OF THE INTERFERON GENE
|
CA3005727A1
(en)
|
2015-11-19 |
2017-05-26 |
Incyte Corporation |
Substituted 2-methylbiphenyl-3-yl heterocyclic compounds and pharmaceutical compositions thereof useful as immunomodulators
|
US20170146519A1
(en)
|
2015-11-20 |
2017-05-25 |
Oregon Health & Science University |
Sting agonists and methods of selecting sting agonists
|
CN107849084B
(zh)
|
2015-12-03 |
2021-09-14 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为sting调节剂的环状嘌呤二核苷酸
|
US20180369268A1
(en)
|
2015-12-16 |
2018-12-27 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"- dependent interferon production
|
WO2017106634A1
(en)
|
2015-12-17 |
2017-06-22 |
Incyte Corporation |
N-phenyl-pyridine-2-carboxamide derivatives and their use as pd-1/pd-l1 protein/protein interaction modulators
|
PE20230731A1
(es)
|
2015-12-22 |
2023-05-03 |
Incyte Corp |
Compuestos heterociclicos como inmunomoduladores
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
US10723756B2
(en)
|
2016-01-11 |
2020-07-28 |
Innate Tumor Immunity Inc. |
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
|
KR20180097751A
(ko)
|
2016-01-11 |
2018-08-31 |
인네이트 튜머 이뮤니티, 인코포레이티드 |
Sting 활성과 연관된 상태 예컨대 암의 치료를 위한 시클릭 디뉴클레오티드
|
US10143746B2
(en)
|
2016-03-04 |
2018-12-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
KR102530488B1
(ko)
|
2016-03-18 |
2023-05-08 |
이뮨 센서, 엘엘씨 |
사이클릭 디-뉴클레오티드 화합물 및 사용 방법
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
KR102527784B1
(ko)
|
2016-04-07 |
2023-04-28 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
단백질 조정제로서 유용한 헤테로시클릭 아미드
|
KR20180132783A
(ko)
|
2016-04-07 |
2018-12-12 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
단백질 조절제로서 유용한 헤테로사이클릭 아미드
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
CN107417564A
(zh)
|
2016-05-23 |
2017-12-01 |
中国医学科学院药物研究所 |
苯醚类衍生物、及其制法和药物组合物与用途
|
ES2905980T3
(es)
|
2016-05-26 |
2022-04-12 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
WO2018009466A1
(en)
|
2016-07-05 |
2018-01-11 |
Aduro Biotech, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
MX2019000216A
(es)
|
2016-07-06 |
2019-11-12 |
Sperovie Biosciences Inc |
Compuestos, composiciones y metodos para el tratamiento de enfermedades.
|
WO2018013887A1
(en)
|
2016-07-15 |
2018-01-18 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
US10300145B2
(en)
|
2016-07-15 |
2019-05-28 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
CN109715202A
(zh)
|
2016-07-15 |
2019-05-03 |
斯必乐维生物科学公司 |
用于治疗疾病的化合物、组合物和方法
|
EP3922279A1
(en)
*
|
2016-08-30 |
2021-12-15 |
Dana Farber Cancer Institute, Inc. |
Drug delivery compositions and uses thereof
|
WO2018045204A1
(en)
|
2016-08-31 |
2018-03-08 |
Ifm Therapeutics, Inc |
Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
CR20190168A
(es)
|
2016-10-04 |
2019-05-17 |
Merck Sharp & Dohme |
Compuestos de benzo[b]tiofeno como agonistas de sting
|
WO2018065360A1
(de)
|
2016-10-07 |
2018-04-12 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh |
Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
RU2019122598A
(ru)
|
2016-12-20 |
2021-01-22 |
Мерк Шарп И Доум Корп. |
Циклические динуклеотидные агонисты sting для лечения рака
|
WO2018118664A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Combinations of pd-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
AU2018212788A1
(en)
|
2017-01-27 |
2019-07-25 |
Janssen Biotech, Inc. |
Cyclic dinucleotides as STING agonists
|
ES2891326T3
(es)
|
2017-01-27 |
2022-01-27 |
Janssen Biotech Inc |
Dinucleótidos cíclicos como agonistas de la STING
|
US20200055883A1
(en)
|
2017-02-17 |
2020-02-20 |
Eisai R&D Management Co., Ltd. |
Cyclic di-nucleotides derivative for the treatment of cancer
|
US10933078B2
(en)
|
2017-02-21 |
2021-03-02 |
Board Of Regents, The University Of Texas System |
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
|
JOP20190218A1
(ar)
|
2017-03-22 |
2019-09-22 |
Boehringer Ingelheim Int |
مركبات ثنائية النيوكليوتيدات حلقية معدلة
|
AR113224A1
(es)
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
Conjugados de anticuerpo que comprenden un agonista de sting
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
EP3621624B1
(en)
|
2017-05-12 |
2023-08-30 |
Merck Sharp & Dohme LLC |
Cyclic di-nucleotide compounds as sting agonists
|
UA125730C2
(uk)
|
2017-06-22 |
2022-05-25 |
Курадев Фарма Лімітед |
Низькомолекулярні модулятори sting людини
|
WO2018234805A1
(en)
|
2017-06-22 |
2018-12-27 |
Curadev Pharma Limited |
SMALL MOLECULAR MODULATORS OF HUMAN STING
|
JP2020524718A
(ja)
|
2017-06-22 |
2020-08-20 |
キュラデブ・ファーマ・リミテッドCuradev Pharma Limited |
ヒトstingの複素環式小分子調節因子
|
KR20200032180A
(ko)
|
2017-07-28 |
2020-03-25 |
브리스톨-마이어스 스큅 컴퍼니 |
항암제로서의 시클릭 디뉴클레오티드
|
US11285131B2
(en)
|
2017-08-04 |
2022-03-29 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene STING agonists for cancer treatment
|
AU2018311965A1
(en)
|
2017-08-04 |
2020-02-13 |
Merck Sharp & Dohme Llc |
Combinations of PD-1 antagonists and benzo[b]thiophene sting antagonists for cancer treatment
|
JP7311514B2
(ja)
|
2017-08-30 |
2023-07-19 |
ベイジン シュエンイー ファーマサイエンシズ カンパニー, リミテッド |
インターフェロン遺伝子刺激因子調節薬としての環状ジヌクレオチド
|
EP3676279B1
(en)
|
2017-08-31 |
2021-12-01 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
US11667663B2
(en)
|
2017-08-31 |
2023-06-06 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
ES2945140T3
(es)
|
2017-08-31 |
2023-06-28 |
Bristol Myers Squibb Co |
Dinucleótidos cíclicos como agentes anticancerosos
|
US11638716B2
(en)
|
2017-08-31 |
2023-05-02 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
WO2019051489A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
US11584774B2
(en)
|
2017-09-11 |
2023-02-21 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
BR112020006780A2
(pt)
|
2017-10-05 |
2020-10-06 |
Glaxosmithkline Intellectual Property Development Limited |
moduladores do estimulador de genes do interferon (sting)
|
EP3692033A1
(en)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting) useful in treating hiv
|
EP3691640A1
(en)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Methods for administering sting agonists
|
KR20200061399A
(ko)
|
2017-10-10 |
2020-06-02 |
브리스톨-마이어스 스큅 컴퍼니 |
항암제로서의 시클릭 디뉴클레오티드
|
WO2019092660A1
(en)
|
2017-11-10 |
2019-05-16 |
Takeda Pharmaceutical Company Limited |
Sting modulator compounds, and methods of making and using
|
EP3713920A4
(en)
|
2017-11-20 |
2021-04-14 |
Silicon Swat, Inc. |
OXOACRIDINYL ACID DERIVATIVES AND METHOD OF USE
|
BR112020010941A2
(pt)
|
2017-12-15 |
2020-11-17 |
Janssen Biotech, Inc. |
dinucleotídeos cíclicos como agonistas de sting
|
WO2019125974A1
(en)
|
2017-12-20 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
WO2019122202A1
(en)
|
2017-12-20 |
2019-06-27 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Sting inhibitors
|
US20190185509A1
(en)
|
2017-12-20 |
2019-06-20 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'2' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
US11203610B2
(en)
|
2017-12-20 |
2021-12-21 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
WO2019123340A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
EP3505188A1
(en)
|
2017-12-29 |
2019-07-03 |
Invivogen |
Pro-cyclic dinucleotide conjugates for cytokine induction
|
CN110016021B
(zh)
|
2018-01-08 |
2021-05-07 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
CN110016025B
(zh)
|
2018-01-08 |
2021-08-06 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
US10519187B2
(en)
|
2018-02-13 |
2019-12-31 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
CA3090746A1
(en)
|
2018-02-16 |
2019-08-22 |
UCB Biopharma SRL |
Pharmaceutical 6,5 heterobicyclic ring derivatives
|
WO2019161171A1
(en)
|
2018-02-16 |
2019-08-22 |
Sperovie Biosciences, Inc. |
Nanoparticle formulations of sting agonists
|
MX2020008771A
(es)
|
2018-02-21 |
2020-11-13 |
Scripps Research Inst |
Agonistas del estimulador de genes interferon.
|
US11945834B2
(en)
|
2018-03-08 |
2024-04-02 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
WO2019170912A1
(en)
|
2018-03-09 |
2019-09-12 |
Lidds Ab |
Bioresorbable controlled-release compositions with sting modulating molecules
|
US10538542B2
(en)
|
2018-03-15 |
2020-01-21 |
Pfizer Inc. |
Cyclopentane-based modulators of STING (stimulator of interferon genes)
|
IL309265A
(en)
|
2018-03-23 |
2024-02-01 |
Codiak Biosciences Inc |
Extracellular vesicles containing agonist-STING
|
EP4242212A3
(en)
|
2018-03-23 |
2023-11-15 |
Takeda Pharmaceutical Company Limited |
Sting modulator compounds with sulfamate linkages, and methods of making and using
|
CN111989338A
(zh)
|
2018-03-27 |
2020-11-24 |
勃林格殷格翰国际有限公司 |
修饰的环二核苷酸化合物
|
CN111971291A
(zh)
|
2018-03-27 |
2020-11-20 |
勃林格殷格翰国际有限公司 |
用作sting激动剂的含有2-氮杂-次黄嘌呤或6h-吡唑并[1,5-d][1,2,4]三嗪-7-酮的环状二核苷酸化合物
|
US11702430B2
(en)
|
2018-04-03 |
2023-07-18 |
Merck Sharp & Dohme Llc |
Aza-benzothiophene compounds as STING agonists
|
BR112020020085A8
(pt)
|
2018-04-03 |
2023-04-11 |
Merck Sharp & Dohme |
Composto, composição farmacêutica, e, métodos para induzir uma resposta imune, para induzir produção de interferons de tipo i dependentes de sting e para tratar um distúrbio de proliferação celular
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
CA3093888A1
(en)
|
2018-04-06 |
2019-10-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides
|
WO2019201283A1
(en)
*
|
2018-04-20 |
2019-10-24 |
Xrad Therapeutics, Inc. |
Dual atm and dna-pk inhibitors for use in anti-tumor therapy
|
TW202014193A
(zh)
|
2018-05-03 |
2020-04-16 |
捷克科學院有機化學與生物化學研究所 |
包含碳環核苷酸之2’3’-環二核苷酸
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
WO2019227007A1
(en)
|
2018-05-25 |
2019-11-28 |
Incyte Corporation |
Tricyclic heterocyclic compounds as sting activators
|
CN112512531B
(zh)
|
2018-06-01 |
2024-04-09 |
卫材R&D管理有限公司 |
用于膀胱癌的治疗的方法
|
US20220402898A1
(en)
|
2018-06-12 |
2022-12-22 |
Ryvu Therapeutics S.A. |
Modulators of stimulator of interferon genes (sting)
|
WO2019243823A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Azaheterocyclic small molecule modulators of human sting
|
WO2019243825A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Small molecule modulators of human sting, conjugates and therapeutic applications
|
JP2021530442A
(ja)
|
2018-06-28 |
2021-11-11 |
ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co., Ltd. |
縮合三環系複素環化合物およびその治療上の使用
|
JP7482122B2
(ja)
|
2018-07-03 |
2024-05-13 |
アイエフエム デュー インコーポレイテッド |
Sting活性に関連する状態を治療するための化合物および組成物
|
TW202014408A
(zh)
|
2018-07-03 |
2020-04-16 |
美商Ifm Due有限公司 |
用於治療與sting活性相關之病症的化合物及組合物
|
EP3820477A4
(en)
|
2018-07-10 |
2022-07-13 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES
|
WO2020010451A1
(en)
|
2018-07-10 |
2020-01-16 |
Trillium Therapeutics Inc. |
Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonists
|
TW202030199A
(zh)
|
2018-07-17 |
2020-08-16 |
美商健生生物科技公司 |
作為sting促效劑之環狀二核苷酸
|
WO2020028566A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
WO2020028565A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Tricyclic heteraryl compounds as sting activators
|
JP2021534250A
(ja)
|
2018-08-24 |
2021-12-09 |
アドライ・ノーティ・バイオファーマ・カンパニー・リミテッドAdlai Nortye Biopharma Co., Ltd. |
高活性stingタンパク質アゴニスト
|
WO2020042995A1
(zh)
|
2018-08-29 |
2020-03-05 |
杭州阿诺生物医药科技有限公司 |
一种高活性sting蛋白激动剂化合物
|
CN112714649A
(zh)
|
2018-09-06 |
2021-04-27 |
第一三共株式会社 |
新型环状二核苷酸衍生物及其抗体药物偶联物
|
CA3113425A1
(en)
|
2018-09-21 |
2020-03-26 |
Shanghai De Novo Pharmatech Co., Ltd. |
Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application
|
CN112888688A
(zh)
|
2018-10-02 |
2021-06-01 |
巴鲁克斯布伦博格研究所 |
苯甲酰胺衍生物作为cgas-sting通路激动剂
|
JP7492523B2
(ja)
|
2018-10-12 |
2024-05-29 |
シャンハイ ジェミンケア ファーマシューティカル カンパニー,リミティド |
環状ジヌクレオチド化合物及びその使用
|
WO2020092127A1
(en)
|
2018-10-29 |
2020-05-07 |
Venenum Biodesign, LLC |
Novel sting agonists
|
MA55138A
(fr)
|
2018-11-19 |
2021-09-29 |
Ifm Due Inc |
Composés et compositions pour traiter des états pathologiques associés à une activité de sting
|
EP3890703B8
(en)
|
2018-12-06 |
2023-10-11 |
GlaxoSmithKline Intellectual Property Development Ltd |
Novel pharmaceutical formulation comprising a sting modulator
|
WO2020117623A1
(en)
|
2018-12-07 |
2020-06-11 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
WO2020117624A1
(en)
|
2018-12-07 |
2020-06-11 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
EP3891164A4
(en)
|
2018-12-07 |
2022-08-24 |
Merck Sharp & Dohme Corp. |
CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
|
CN113195473B
(zh)
|
2018-12-14 |
2022-11-22 |
江苏恒瑞医药股份有限公司 |
三环化合物作为sting激动剂及其制备方法和医药用途
|
CN111655712B
(zh)
|
2018-12-29 |
2021-02-05 |
上海济煜医药科技有限公司 |
作为肿瘤免疫类的化合物及其应用
|
WO2020146237A1
(en)
|
2019-01-07 |
2020-07-16 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
CN111471056B
(zh)
|
2019-01-23 |
2021-07-02 |
成都先导药物开发股份有限公司 |
一种大环类免疫调节剂
|
CN111499617B
(zh)
|
2019-01-31 |
2021-08-06 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
US20230357306A1
(en)
|
2019-02-05 |
2023-11-09 |
Bristol-Myers Squibb Company |
Synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3'-amino-3'-deoxyadenosine and 3'-amino-3'-deoxyguanosine and the protected derivatives thereof
|
WO2020178769A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
JP7350872B2
(ja)
|
2019-03-07 |
2023-09-26 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
3’3’-環状ジヌクレオチドおよびそのプロドラッグ
|
BR112021018947A2
(pt)
|
2019-03-28 |
2022-02-08 |
Lupin Ltd |
Compostos macrocíclicos como agonistas de sting
|
TW202104214A
(zh)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
化合物
|
CN113518776B
(zh)
|
2019-04-30 |
2024-03-26 |
四川科伦博泰生物医药股份有限公司 |
苯并噻吩类化合物及其制备方法和用途
|
CA3137119A1
(en)
|
2019-05-09 |
2020-11-12 |
Aligos Therapeutics, Inc. |
Modified cyclic dinucleoside compounds as sting modulators
|
JP2022533194A
(ja)
|
2019-05-16 |
2022-07-21 |
スティングセラ インコーポレイテッド |
ベンゾ[b][1,8]ナフチリジン酢酸誘導体および使用方法
|
US20220227761A1
(en)
|
2019-05-16 |
2022-07-21 |
Stingthera, Inc. |
Oxoacridinyl acetic acid derivatives and methods of use
|
WO2020236586A1
(en)
|
2019-05-17 |
2020-11-26 |
Ifm Due, Inc. |
N-hetaryl-squaramide compounds for treating conditions associated with sting activity
|
JP2022535743A
(ja)
|
2019-05-29 |
2022-08-10 |
アイエフエム デュー インコーポレイテッド |
Sting活性に関連する状態を治療するための化合物および組成物
|
BR112021024948A2
(pt)
|
2019-06-12 |
2022-01-25 |
Ryvu Therapeutics S A |
Moduladores de próxima geração de estimulador de genes de interferon (sting)
|
JP2022536755A
(ja)
|
2019-06-14 |
2022-08-18 |
アイエフエム デュー インコーポレイテッド |
Sting活性に関連する状態を治療するための化合物および組成物
|
WO2021000770A1
(zh)
|
2019-07-02 |
2021-01-07 |
凯复制药有限公司 |
可增强免疫活性的杂环化合物、其制备方法及其在医药上的应用
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
US20220289763A1
(en)
|
2019-07-22 |
2022-09-15 |
Lupin Limited |
Macrocyclic Compounds as Sting Agonists and Methods and Uses Thereof
|
CN114174285B
(zh)
|
2019-07-25 |
2023-10-31 |
上海济煜医药科技有限公司 |
杂环酰胺类化合物及其制备方法和应用
|
CN114206898A
(zh)
|
2019-07-25 |
2022-03-18 |
百济神州有限公司 |
作为sting激动剂的环状二核苷酸
|
CN114585623A
(zh)
|
2019-08-02 |
2022-06-03 |
梅尔莎纳医疗公司 |
双[N-((5-氨基甲酰基)-1H-苯并[d]咪唑-2-基)吡唑-5-甲酰胺]衍生物和相关化合物作为STING(干扰素基因刺激物)激动剂用于治疗癌症
|
JP7485399B2
(ja)
|
2019-08-21 |
2024-05-16 |
ザ スクリプス リサーチ インスティテュート |
インターフェロン遺伝子の刺激因子stingの単環式アゴニスト
|
MX2022002152A
(es)
|
2019-08-21 |
2022-05-18 |
Scripps Research Inst |
Agonistas biciclicos del estimulador de genes de interferon sting.
|
CN112442033A
(zh)
|
2019-08-28 |
2021-03-05 |
迈德欣国际有限公司 |
Sting通路调节剂及其用途
|
US20220267270A1
(en)
|
2019-08-30 |
2022-08-25 |
University Of South Florida |
Sting modulators, compositions, and methods of use
|
EP4134134A4
(en)
*
|
2020-04-10 |
2023-12-27 |
ONO Pharmaceutical Co., Ltd. |
STING AGONIST COMPOUND
|
JP2023072104A
(ja)
*
|
2020-04-10 |
2023-05-24 |
小野薬品工業株式会社 |
抗体薬物複合体
|